z-logo
open-access-imgOpen Access
Giant Hepatic Hemangioma With Kasabach–MerrittSyndrome: Is the Appropriate TreatmentEnucleation or Liver Transplantation?
Author(s) -
Steven N. Hochwald,
Leslie H. Blumgart
Publication year - 2000
Publication title -
hpb surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.561
H-Index - 26
eISSN - 1607-8462
pISSN - 0894-8569
DOI - 10.1155/2000/25954
Subject(s) - kasabach–merritt syndrome , medicine , enucleation , liver transplantation , hemangioma , liver hemangioma , transplantation , surgery , general surgery
We present a case of giant cavernous hemangioma of the liver with disseminated intravascular coagulopathy (Kasabach-Merritt syndrome) which was cured by enucleation. The 51 year old woman presented with increased abdominal girth and easy bruisability. Workup elsewhere revealed a massive hepatic hemangioma and she was started on radiation therapy to the lesion and offered an orthotopic liver transplant. After careful preoperative preparation, we felt that resection was possible and she underwent a successful enucleation. The operation and postoperative course were complicated by bleeding but she recovered and remains well in followup after 6 months. All coagulation parameters have returned to normal. Enucleation should be considered the treatment of choice for hepatic hemangiomas, including those presenting with Kasabach-Merritt syndrome. The benefits of enucleation as compared to liver transplantation for these lesions are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom